Clinical and laboratory signs of mitochondrial dysfunction secondary to nucleoside analogue antiretroviral therapy are reversible

Scandinavian Journal of Infectious Diseases

Volumn 33, Issue 7, 2001, Pages 558-

  Hagberg, L ^a   Janson, G L ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIDANOSINE; LACTIC ACID; LIVER ENZYME; METOPROLOL; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ADULT; ARM; BUTTOCK; CASE REPORT; CLINICAL FEATURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG WITHDRAWAL; FATIGUE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LACTATE BLOOD LEVEL; LEG; NOTE; POLYNEUROPATHY; WEIGHT GAIN; WEIGHT REDUCTION;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DIDANOSINE; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; MITOCHONDRIAL DISEASES; REVERSE TRANSCRIPTASE INHIBITORS; STAVUDINE;

EID: 17944363043     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540110026854     Document Type: Note

References (4)

1. Mitochondrial toxicity: Potential mechanisms and experimental evidence
2. Lactic acidosis secondary to nucleoside analogue antiretroviral therapy
3. A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy
4. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection